As of Sep 26
| -0.62 / -1.81%|
The 20 analysts offering 12-month price forecasts for Pfizer have a median target of 39.00, with a high estimate of 54.00 and a low estimate of 33.00. The median estimate represents a +15.93% increase from the last price of 33.64.
The current consensus among 22 polled investment analysts is to Buy stock in Pfizer. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.